| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/08/2006 | EP1623039A2 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| 02/08/2006 | EP1623016A2 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3 |
| 02/08/2006 | EP1623012A2 ANTISENSE ANTIVIRAL AGENT AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
| 02/08/2006 | EP1623011A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| 02/08/2006 | EP1623010A2 Preservation of rna in a biological sample |
| 02/08/2006 | EP1622935A2 Spex compositions and methods of use |
| 02/08/2006 | EP1622923A2 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
| 02/08/2006 | EP1622921A2 Variants of beta-glucosidases |
| 02/08/2006 | EP1622638A2 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 02/08/2006 | EP1622635A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 02/08/2006 | EP1622634A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/08/2006 | EP1622566A2 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 02/08/2006 | EP1419274A4 Modular assembly of nucleic acid-protein fusion multimers |
| 02/08/2006 | EP1404696B1 Activators for oligonucleotide synthesis |
| 02/08/2006 | EP1297006B1 Regulation of human prostasin-like serine protease |
| 02/08/2006 | EP1007657B1 Hiv-specific oligonucleotides and methods of their use |
| 02/08/2006 | EP0988045B1 Peptide nucleic acid monomers and oligomers |
| 02/08/2006 | EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/08/2006 | EP0687296B1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 02/08/2006 | EP0648266B1 Elicitor of the hypersensitive response in plants |
| 02/08/2006 | CN1732272A Assay for rnase h activity |
| 02/08/2006 | CN1732181A Nucleotide derivatives and DNA microarray |
| 02/08/2006 | CN1732176A Process for preparing phosphorodiamidites |
| 02/08/2006 | CN1732018A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/08/2006 | CN1730668A Molecular mark of watermelon linked to gene resistant to field pumpkin yellowwatermelon yellow mosaic virus and uses |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240835C Nucleotide specific to o antigen of colibacillus 0-59 |
| 02/07/2006 | US6995274 Cyanine dyes |
| 02/07/2006 | US6995259 efficient solid phase synthesis using a dimethoxytrityl (DMT) protected nucleoside succinate such as 5'-O-DMT-3'-O-succinyl uridine linked to a solid support such as controlled pore glass |
| 02/07/2006 | US6995258 Nucleolar targeting of therapeutics against HIV |
| 02/07/2006 | US6995257 Notch3 gene and the corresponding protein, which are involved in CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy); probes and primers; mutations in gene that indicate risk of developing CADASIL |
| 02/07/2006 | US6995255 Cellular delivery agent |
| 02/07/2006 | US6995254 Given sequences; vectors; host cells; use as a drug target to screen for novel antibiotics as FAB I is involved in bacterial fatty acid biosynthesis |
| 02/07/2006 | US6995252 A polynucleotide encoding a perinuclear thecaprotein (PT 32) which binds to tyrosine kinase c-Yes to induce oocyte activation; enhancing fertility, treating or diagnosing diminished fertility and/or abnormal spermiogenesis; contraception; screeing |
| 02/07/2006 | US6995251 Ovary-specific genes and proteins |
| 02/07/2006 | US6995250 Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium |
| 02/07/2006 | US6995249 Nucleic acid capable of binding specifically to Ras target protein |
| 02/07/2006 | US6995248 Bipolymer for use in the generation of solid support |
| 02/07/2006 | US6995147 Method of delaying the onset of diabetes |
| 02/07/2006 | US6995146 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 02/07/2006 | US6995020 Pressure cooking sample with ammonia, ethanol in sodium borohydride; pretreatment of FISH analysis, reduce the tissue autofluorescence for improving the detection of mRNA transcripts in paraffin-embedded tissue |
| 02/07/2006 | US6995017 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 02/07/2006 | US6995004 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β 1,3-N-ACETYLGALACTOSAMINE-α-R / N-ACETYLGLUCOSAMINE-β 1,3,-N-ACETYLGALACTOSAMINE-α-R (GLCNAC TO GALNAC) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2/4GNT |
| 02/07/2006 | US6994998 substituting a base-modified nucleotide that renders the polynucleotide more susceptible to cleavage at the sites of its incorporation for a natural nucleotide in a polynucleotide; 1-ribose-4-amino-5-hydroxy-1,2-dihydropyrimidin-2-one for example |
| 02/07/2006 | US6994996 polypeptide able to regulate ATPase activity; use treating various disease such as malignant tumors, hemopathies, HIV infections, immune diseases and inflammations |
| 02/07/2006 | US6994995 Specified sequences; expression vectors and host cells; share sequence similarity with mammalian synaptotagmins which have been implicated in membrane traffic and calcium dependent neuroexocytosis and are drug targets |
| 02/07/2006 | US6994991 Identification of differentially methylated multiple drug resistance loci |
| 02/07/2006 | US6994978 Human osteoclast derived cathepsin |
| 02/07/2006 | US6994972 Porous substrates for DNA arrays |
| 02/07/2006 | US6994969 Combination of several different mass spectra, obtained after complementary digestion reactions, coupled with systematic computational analysis leads to the unambiguous assignment of both known and previously unknown sequence variations |
| 02/07/2006 | US6994965 Visual comfirmation of similarity score calculated from base sequences of probe biopolymers represented by, e.g., square patterns having varying depths in color; accuracy; side by side display for comparison; unexpected hybridization; microarrays |
| 02/07/2006 | US6994964 Macromolecular arrays on polymeric brushes and methods for preparing the same |
| 02/07/2006 | US6994963 Methods for recombinatorial nucleic acid synthesis |
| 02/07/2006 | US6994962 Methods of identifying point mutations in a genome |
| 02/07/2006 | US6994960 Detecting a mutation between a nucleic acid molecule to be tested and a reference nucleic acid molecule by base specific cleavage followed by Matrix-Assisted Laser Desorption/Ionization MS; does it require a gel electrophoresis step |
| 02/07/2006 | US6994959 which compete with DNA-binding sites of regulatory proteins which regulate t-cell activity (CD28 and cytokines), preventing transcription; analyzing immunocompetence; for treatment of autoimmune diseases |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994860 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 02/07/2006 | US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 02/07/2006 | CA1341495C Method for detecting nucleic acid sequences |
| 02/02/2006 | WO2005118882A3 Method for the taxon-specific identification of cells of gram-positive bacteria and devices for carrying out said method |
| 02/02/2006 | WO2005097992A3 Modified polynucleotides for reducing off-target effects in rna interference |
| 02/02/2006 | WO2005047245A3 Fluorescence assays with improved blocking groups |
| 02/02/2006 | WO2004101753A3 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 02/02/2006 | WO2004060301A3 Novel compositions and methods in cancer |
| 02/02/2006 | WO2004058940A3 Sirna-mediated gene silencing |
| 02/02/2006 | WO2003102166A3 Novel flavivirus antigens |
| 02/02/2006 | US20060026719 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 02/02/2006 | US20060026716 Transcriptional activators involved in abiotic stress tolerance |
| 02/02/2006 | US20060026713 Nucleotide sequences coding beta ketoacyl-acyl carrier protein synthase II for use in modifying fatty acid concentration in crop plants |
| 02/02/2006 | US20060026707 Isolated from Zea mays; transformed plant; can be used to repress the expression of a desired target gene in specific plant tissue or to prevent the repression of a particular desired target gene |
| 02/02/2006 | US20060026705 Plant amino acid biosynthetic enzymes |
| 02/02/2006 | US20060026698 Transgenic transchromosomal rodents for making human antibodies |
| 02/02/2006 | US20060026696 Humanized immunoglobulin loci |
| 02/02/2006 | US20060025582 Promoter sequences for corticotropin releasing-factor receptor CRF2alpha and method of identifying agents that alter the activity of the promoter sequences |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025580 Novel human estrogen receptor beta |
| 02/02/2006 | US20060025574 32 human secreted proteins |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060025572 Mammalian cell surface antigens; related reagents |
| 02/02/2006 | US20060025374 Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
| 02/02/2006 | US20060025373 Modulation of glucocorticoid receptor expression |
| 02/02/2006 | US20060025372 Antisense modulation of PTP1B expression |
| 02/02/2006 | US20060025371 Methods of inhibiting COX-2 |
| 02/02/2006 | US20060025370 Methods of inhibiting VEGF-C |
| 02/02/2006 | US20060025369 Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD) |
| 02/02/2006 | US20060025366 Short intefering sequences comprising 1,2-DiLinoleyloxy-N,N-dimethylaminopropane (DLinDMA) or 1,2-Dilinolenyloxy-N,N-dimethylaminopropane (DLenDMA) for use in silencing target gene sequences |
| 02/02/2006 | US20060025365 Immunostimulatory oligonucleotide multimers |
| 02/02/2006 | US20060025361 treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes (eg. type II and type I diabetes); host cells; bioassays for identifying a component of a PTP-1B signal transduction pathway |
| 02/02/2006 | US20060025360 Human cervical cancer protooncogene and protein encoded therein |
| 02/02/2006 | US20060025341 Isolated polynucleotide encoding inhibin-related proteins for treating cancer of epithelial, testicular, ovarian, prostate; biodrug protein; activin binding activity; hormone inhibitor; muscle regeneration |
| 02/02/2006 | US20060024809 Ceramidase gene |
| 02/02/2006 | US20060024808 Covalent tethering of functional groups to proteins and substrates therefor |
| 02/02/2006 | US20060024807 Kinase nucleic acids and polypeptides encoded by these nucleic acids; kinase inhibiitor design and indentifying inhibitors |
| 02/02/2006 | US20060024806 Mycolactone locus: an assembly line for producing novel polyketides, therapeutic and prophylactic uses |
| 02/02/2006 | US20060024805 Disintegrin homologs |
| 02/02/2006 | US20060024804 Isoforms isolated and purified from mammalian colostrum |
| 02/02/2006 | US20060024797 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024794 Novel methods for production of di-chain botulinum toxin |